ANI Pharmaceuticals Completes $210m Novitium Acquisition
Acquisition Expected To Bolster R&D, Generics Scale And CDMO Business
ANI Pharmaceuticals has completed its acquisition of niche generics specialist Novitium Pharma, securing access to a pipeline of generics and 505(b)(2) candidates that has expanded further since the deal was announced earlier in the year.
